IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
IQVIA Holdings Inc.NYSE: IQV
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) dips below year-ago levels
Q2 FY2026 EPS (Diluted) of $1.53 fell 0.6% year over year, behind the +16.6% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 5.0% from the prior quarter. Over 3 fiscal years it compounded at +11.1% a year.
Context
- EPS (Diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 13 analysts of $12.96 (+65.3%) for the fiscal year ending Dec 2026, a step up from the +4.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.53-5.0% QoQ
- Last fiscal yearDec 2025
- $7.84+4.7% YoY
- LTMJun 2026
- $8.06+16.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.6% | +68.9% | +69.5 pp |
| 1 year | +4.7% | +65.3% | +60.7 pp |
| 3-year CAGR | +11.1% | +26.6% | +15.5 pp |
| 5-year CAGR | +20.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 7.84 USD
- Year-over-year change
- +4.7%
- 4-year CAGR
- +12.2%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.84 | +4.7% |
| FY2024 | 2024-12-31 | 7.49 | +2.7% |
| FY2023 | 2023-12-31 | 7.29 | +27.4% |
| FY2022 | 2022-12-31 | 5.72 | +15.6% |
| FY2021 | 2021-12-31 | 4.95 | — |
EPS (Diluted) vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's LTM Jun 2026 EPS (Diluted) of $8.06 is the 2nd highest of the 9 companies compared; the peer median is -$0.51.
- Its year-over-year change of +16.6% is the 4th highest of 9, against a peer median of -22.6%.
- Over three fiscal years its annual growth of +11.1% compares with a peer median of +21.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $18.04 | +26.1% | +28.0% | |
| LTM Jun 2026 | $8.06 | +16.6% | +11.1% | |
| LTM Jul 2026 | $6.08 | +25.1% | +21.9% | |
| LTM Jun 2026 | $4.26 | -56.2% | -22.1% | |
| LTM Mar 2026 | -$0.1 | -505.1% | — | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | -$0.93 | +91.9% | — |
| LTM Sep 2026 | -$1.06 | +10.9% | — | |
| LTM Mar 2026 | -$3.72 | -223.5% | — | |
| LTM Jun 2026 | -$4.85 | -264.7% | — | |
| Peer median (excluding IQV) | -$0.51 | -22.6% | +21.9% | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.87B | 14.41B | 14.98B | 15.41B | 16.31B |
| Cost of Revenue | 9.23B | 9.38B | 9.75B | 10.03B | 10.88B |
| Gross Profit | 4.64B | 5.03B | 5.24B | 5.38B | 5.43B |
| Gross Margin | 33.5% | 34.9% | 35.0% | 34.9% | 33.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.96B | 2.07B | 2.05B | 1.99B | 1.99B |
| Operating Expenses | 3.25B | 3.23B | 3.26B | 3.17B | 3.25B |
| Depreciation & Amortization | 1.26B | 1.13B | 1.13B | 1.11B | 640M |
| EBITDA | 2.77B | 2.91B | 3.26B | 3.45B | 2.94B |
| EBITDA Margin | 19.9% | 20.2% | 21.7% | 22.4% | 18.0% |
| Operating Income | 1.39B | 1.8B | 1.98B | 2.2B | 2.18B |
| Operating Margin | 10.0% | 12.5% | 13.2% | 14.3% | 13.4% |
| Interest Income | 6M | 13M | 36M | 47M | 45M |
| Interest Expense | 375M | 416M | 672M | 670M | 729M |
| Other Income / Expenses | (259M) | (448M) | (518M) | (533M) | (569M) |
| Income Before Tax | 1.13B | 1.35B | 1.46B | 1.67B | 1.61B |
| Pre-Tax Margin | 8.2% | 9.4% | 9.7% | 10.8% | 9.9% |
| Income Tax Expense | 163M | 260M | 101M | 296M | 252M |
| Net Income | 966M | 1.09B | 1.36B | 1.37B | 1.36B |
| Net Margin | 7.0% | 7.6% | 9.1% | 8.9% | 8.3% |
| EPS (Basic) | 5.05 | 5.82 | 7.39 | 7.57 | 7.91 |
| EPS (Diluted) | 4.95 | 5.72 | 7.29 | 7.49 | 7.84 |
| Weighted Avg Shares | 191.4M | 187.6M | 183.8M | 181.3M | 171.9M |
| Weighted Avg Shares (Diluted) | 195M | 190.6M | 186.3M | 183.4M | 173.5M |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.